Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
escherichia coli nissle 1917 (1 trial)
curcumin (4 trials)
6-prenylnaringenin (2 trials)
8-prenyl-naringenin (1 trial)
resveratrol (1 trial)
rice bran (1 trial)
bifidobacterium lactis (1 trial)
caffeine (1 trial)
eicosapentanoic acid (1 trial)
genistein (1 trial)
Lactobacillus acidophilus (1 trial)
lactobacillus paracasei (1 trial)
maltodextrin (1 trial)
omega-3 fatty acids (omacor) (2 trials)
orange juice (1 trial)
phaeodactylum (1 trial)
resistant starch (1 trial)
taurine (1 trial)
turmeric (1 trial)
vitamin d (1 trial)
xanthaurine (1 trial)
Colorectal Neoplasms (Phase 3)
Metabolic Syndrome (Phase 2)
Stomach Neoplasms (Phase 3)
Syndrome (Phase 2)
Trials (18 total)
Trial APIs (21 total)